Davidson Capital Management »

Halozyme Therapeutics shares owned by Davidson Capital Management

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Davidson Capital Management from 13F filings

Historical chart of Davidson Capital Management investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Davidson Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Davidson Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.5M 27k 57.24
2024-06-30 $9.9k 190 52.36
2024-03-31 $7.5k 184 40.68